Polymeric IgA is superior to monomeric IgA and IgG carrying the same variable domain in preventing Clostridium difficile toxin A damaging of T84 monolayers

被引:77
作者
Stubbe, H
Berdoz, J
Kraehenbuhl, JP
Corthésy, B
机构
[1] CHU Vaudois, Div Immunol & Allergy, CH-1011 Lausanne, Switzerland
[2] Swiss Inst Expt Canc Res, CH-1066 Epalinges, Switzerland
关键词
D O I
10.4049/jimmunol.164.4.1952
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The two exotoxins A and B produced by Clostridium difficile are responsible for antibiotic-associated enterocolitis in human and animals. When added apically to human colonic carcinoma derived T84 cell monolayers, toxin A, but not toxin B, abolished the transepithelial electrical resistance and altered the morphological integrity. Apical addition of suboptimal concentration of toxin A made the cell monolayer sensitive to toxin B, Both toxins induced drastic and rapid epithelial alterations when applied basolaterally with a complete disorganization of tight junctions and vacuolization of the cells, Toxin A-specific IgG2a from hybridoma PCG-4 added apically with toxin A alone or in combination with toxin B abolished the toxin-induced epithelial alterations for up to 8 h, The Ab neutralized basolateral toxin A for 4 h, but not the mixture of the two toxins, Using an identical Ab:Ag ratio, we found that recombinant polymeric IgA (IgA(d/p)) with the same Fv fragments extended protection against toxin A for at least 24 h in both compartments. In contrast, the recombinant monomeric IgA counterpart behaved as the PCG-4 IgG2a Ab, The direct comparison between different Ig isotype and molecular forms, but of unique specificity, demonstrates that IgA(d/p) Ab is more efficient in neutralizing toxin A than monomeric IgG and IgA, We conclude that immune protection against C, difficile toxins requires toxin A-specific secretory Abs in the intestinal lumen and IgA(d/p) specific for both toxins in the lamina propria.
引用
收藏
页码:1952 / 1960
页数:9
相关论文
共 69 条
[1]   CHARACTERIZATION OF ZO-1, A PROTEIN-COMPONENT OF THE TIGHT JUNCTION FROM MOUSE-LIVER AND MADIN-DARBY CANINE KIDNEY-CELLS [J].
ANDERSON, JM ;
STEVENSON, BR ;
JESAITIS, LA ;
GOODENOUGH, DA ;
MOOSEKER, MS .
JOURNAL OF CELL BIOLOGY, 1988, 106 (04) :1141-1149
[2]  
BEAGLEY KW, 1992, GASTROENTEROL CLIN N, V21, P347
[3]   In vitro comparison of the antigen-binding and stability properties of the various molecular forms of IgA antibodies assembled and produced in CHO cells [J].
Berdoz, J ;
Blanc, CT ;
Reinhardt, M ;
Kraehenbuhl, JP ;
Corthésy, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (06) :3029-3034
[4]  
Berdoz J, 1995, ANIMAL CELL TECHNOLOGY: DEVELOPMENTS TOWARDS THE 21ST CENTURY, P463
[5]  
Berneman A, 1998, INFECT IMMUN, V66, P4163
[6]   EFFECTS OF PURIFIED CLOSTRIDIUM-DIFFICILE TOXIN-A ON RABBIT DISTAL COLON [J].
BURAKOFF, R ;
ZHAO, LM ;
CELIFARCO, AJ ;
ROSE, KL ;
DONOVAN, V ;
POTHOULAKIS, C ;
PERCY, WH .
GASTROENTEROLOGY, 1995, 109 (02) :348-354
[7]   SACCHAROMYCES-BOULARDII FOR CLOSTRIDIUM-DIFFICILE-ASSOCIATED ENTEROPATHIES IN INFANTS [J].
BUTS, JP ;
CORTHIER, G ;
DELMEE, M .
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 1993, 16 (04) :419-425
[8]   Neurokinin-1 (NK-1) receptor is required in Clostridium difficile-induced enteritis [J].
Castagliuolo, I ;
Riegler, M ;
Pasha, A ;
Nikulasson, S ;
Lu, B ;
Gerard, C ;
Gerard, NP ;
Pothoulakis, C .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (08) :1547-1550
[9]  
Castagliuolo I, 1998, J IMMUNOL, V160, P6039
[10]   Toxins A and B from Clostridium difficile differ with respect to enzymatic potencies, cellular substrate specificities, and surface binding to cultured cells [J].
ChavesOlarte, E ;
Weidmann, M ;
vonEichelStreiber, C ;
Thelestam, M .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (07) :1734-1741